MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


0026-895X/04/6501-121-129$20.00
Mol Pharmacol 65:121-129, 2004

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dunah, A. W.
Right arrow Articles by Standaert, David. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dunah, A. W.
Right arrow Articles by Standaert, David. G.

Dopamine D1-Dependent Trafficking of Striatal N-Methyl-D-aspartate Glutamate Receptors Requires Fyn Protein Tyrosine Kinase but Not DARPP-32

Anthone W. Dunah, Ana C. Sirianni, Allen A. Fienberg, Elena Bastia, Michael A. Schwarzschild, and David. G. Standaert

Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Center for Aging, Genetics, and Neurodegeneration, Charlestown, Massachusetts (A.W.D., A.C.S., E.B., M.A.S., D.G.S.); and Laboratory of Molecular and Cellular Neuroscience, The Rockefeller University, New York, New York (A.A.F.)

Interactions between dopaminergic and glutamatergic systems in the striatum are thought to underlie both the symptoms and adverse effects of treatment of Parkinson's disease. We have previously reported that activation of the dopamine D1 receptor triggers a rapid redistribution of striatal N-methyl-D-aspartate (NMDA) receptors between intracellular and postsynaptic sub-cellular compartments. To unravel the signaling pathways underlying this trafficking, we studied mice with targeted disruptions of either the gene that encodes the dopamine- and cAMP-regulated phosphoprotein (DARPP-32), a potent and selective inhibitor of protein phosphatase-1, or the protein tyrosine kinase Fyn. In striatal tissue from DARPP-32-depleted mice, basal tyrosine and serine phosphorylation of striatal NMDA receptor subunits NR1, NR2A, and NR2B was normal, and activation of dopamine D1 receptors with the agonist SKF-82958 [(±)-6-chloro-7,8-dihydroxy-3-allyl-1-phenyl-2,3,4,5-tetra-hydro-1H-benzazepine] produced redistribution of NMDA receptors from vesicular compartments (P3 and LP2) to synaptosomal membranes (LP1). In the Fyn knockout mice, basal tyrosine phosphorylation of NR2A and NR2B was drastically reduced, whereas serine phosphorylation of these NMDA subunits was unchanged. In the Fyn knockout mice, the dopamine D1 receptor agonist failed to induce subcellular redistribution of NMDA receptors. In addition, Fyn-depleted mice lesioned with 6-hydroxydopamine also failed to exhibit L-DOPA-induced behavioral sensitization, but this may be caused, at least in part, by resistance of these mice to the neurotoxic lesion. These findings suggest a novel mechanism for the trafficking of striatal NMDA receptors by signaling pathways that are independent of DARPP-32 but require Fyn protein tyrosine kinase. Strategies that prevent NMDA receptor subcellular redistribution through inhibition of Fyn kinase may prove useful in the treatment of Parkinson's disease.


Received July 21, 2003; accepted September 26, 2003

Address correspondence to: Dr. David G. Standaert, Department of Neurology, Massachusetts General Hospital, Center for Aging, Genetics, and Neurodegeneration, 114 16th Street, CNY114-2004, Charlestown, MA 02129. E-mail: standaert{at}helix.mgh.harvard.edu




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
D. Rylander, A. Recchia, F. Mela, A. Dekundy, W. Danysz, and M. A. Cenci
Pharmacological Modulation of Glutamate Transmission in a Rat Model of L-DOPA-Induced Dyskinesia: Effects on Motor Behavior and Striatal Nuclear Signaling
J. Pharmacol. Exp. Ther., July 1, 2009; 330(1): 227 - 235.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
N. P. Lapointe, P. Rouleau, R.-V. Ung, and P. A. Guertin
Specific role of dopamine D1 receptors in spinal network activation and rhythmic movement induction in vertebrates
J. Physiol., April 1, 2009; 587(7): 1499 - 1511.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
H. Tong and A. J. Gibb
Dopamine D1 receptor inhibition of NMDA receptor currents mediated by tyrosine kinase-dependent receptor trafficking in neonatal rat striatum
J. Physiol., October 1, 2008; 586(19): 4693 - 4707.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
X. Sun, M. Milovanovic, Y. Zhao, and M. E. Wolf
Acute and Chronic Dopamine Receptor Stimulation Modulates AMPA Receptor Trafficking in Nucleus Accumbens Neurons Cocultured with Prefrontal Cortex Neurons
J. Neurosci., April 16, 2008; 28(16): 4216 - 4230.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H.-Y. Wu, F.-C. Hsu, A. J. Gleichman, I. Baconguis, D. A. Coulter, and D. R. Lynch
Fyn-mediated Phosphorylation of NR2B Tyr-1336 Controls Calpain-mediated NR2B Cleavage in Neurons and Heterologous Systems
J. Biol. Chem., July 13, 2007; 282(28): 20075 - 20087.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
Y. Tu, S. Kroener, K. Abernathy, C. Lapish, J. Seamans, L. J. Chandler, and J. J. Woodward
Ethanol Inhibits Persistent Activity in Prefrontal Cortical Neurons
J. Neurosci., April 25, 2007; 27(17): 4765 - 4775.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. Wang, S. Carnicella, K. Phamluong, J. Jeanblanc, J. A. Ronesi, N. Chaudhri, P. H. Janak, D. M. Lovinger, and D. Ron
Ethanol Induces Long-Term Facilitation of NR2B-NMDA Receptor Activity in the Dorsal Striatum: Implications for Alcohol Drinking Behavior
J. Neurosci., March 28, 2007; 27(13): 3593 - 3602.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Viviani, F. Gardoni, S. Bartesaghi, E. Corsini, A. Facchi, C. L. Galli, M. Di Luca, and M. Marinovich
Interleukin-1beta Released by gp120 Drives Neural Death through Tyrosine Phosphorylation and Trafficking of NMDA Receptors
J. Biol. Chem., October 6, 2006; 281(40): 30212 - 30222.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
B. Schilstrom, R. Yaka, E. Argilli, N. Suvarna, J. Schumann, B. T. Chen, M. Carman, V. Singh, W. S. Mailliard, D. Ron, et al.
Cocaine Enhances NMDA Receptor-Mediated Currents in Ventral Tegmental Area Cells via Dopamine D5 Receptor-Dependent Redistribution of NMDA Receptors.
J. Neurosci., August 15, 2006; 26(33): 8549 - 8558.
[Abstract] [Full Text] [PDF]


Home page
Sci SignalHome page
C. Cepeda and M. S. Levine
Where Do You Think You Are Going? The NMDA-D1 Receptor Trap
Sci. Signal., May 2, 2006; 2006(333): pe20 - pe20.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
P. J. Hallett, R. Spoelgen, B. T. Hyman, D. G. Standaert, and A. W. Dunah
Dopamine D1 activation potentiates striatal NMDA receptors by tyrosine phosphorylation-dependent subunit trafficking.
J. Neurosci., April 26, 2006; 26(17): 4690 - 4700.
[Abstract] [Full Text] [PDF]


Home page
NeuroscientistHome page
C. R. Yang and L. Chen
Targeting Prefrontal Cortical Dopamine D1 and N-Methyl-D-Aspartate Receptor Interactions in Schizophrenia Treatment
Neuroscientist, October 1, 2005; 11(5): 452 - 470.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
N. Suvarna, S. L. Borgland, J. Wang, K. Phamluong, Y. P. Auberson, A. Bonci, and D. Ron
Ethanol Alters Trafficking and Functional N-Methyl-D-aspartate Receptor NR2 Subunit Ratio via H-Ras
J. Biol. Chem., September 9, 2005; 280(36): 31450 - 31459.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics